Gratus Capital’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$17M Buy
86,703
+2,317
+3% +$479K 0.68% 41
2024
Q1
$18.2M Buy
84,386
+1,338
+2% +$281K 0.83% 35
2023
Q4
$17.5M Sell
83,048
-420
-0.5% -$89.6K 0.99% 28
2023
Q3
$16.7M Sell
83,468
-293
-0.3% -$58.2K 1.13% 24
2023
Q2
$15.5M Buy
83,761
+1,745
+2% +$322K 1.06% 26
2023
Q1
$15.7M Sell
82,016
-2,166
-3% -$392K 1.2% 24
2022
Q4
$14.2M Buy
84,182
+26,550
+46% +$4.61M 1.16% 29
2022
Q3
$10.2M Buy
57,632
+5,289
+10% +$1.05M 1.08% 38
2022
Q2
$10.7M Buy
52,343
+2,710
+5% +$574K 1.2% 34
2022
Q1
$11.8M Buy
49,633
+2,222
+5% +$522K 1.13% 33
2021
Q4
$10.8M Buy
47,411
+1,605
+4% +$353K 1% 36
2021
Q3
$8.86M Buy
45,806
+2,133
+5% +$432K 0.95% 44
2021
Q2
$9.29M Buy
43,673
+4,004
+10% +$845K 1.03% 41
2021
Q1
$8.1M Sell
39,669
-6,733
-15% -$1.33M 0.97% 42
2020
Q4
$8.45M Buy
46,402
+2,066
+5% +$351K 1.13% 36
2020
Q3
$7.42M Buy
44,336
+1,388
+3% +$234K 1.16% 33
2020
Q2
$6.98M Buy
+42,948
New +$7.7M 1.18% 36

Other funds holding CME

Gratus Capital's CME Position: Q2 2024 in Review

Gratus Capital increased its CME Group (CME) stake by 2.7% in Q2 2024, buying an estimated $479K and bringing the position to 86,703 shares worth $17M. The position accounts for 0.68% of the portfolio, ranked #41.

Gratus Capital first reported a position in CME in Q2 2020 and has held it in 17 quarters since. The position peaked at $18.2M in Q1 2024. 1,377 funds tracked by Wall St. Rank hold CME as of Q2 2024.

  • Gratus Capital held 86,703 shares of CME Group worth $17M as of Q2 2024.
  • Gratus Capital bought 2,317 CME Group shares in Q2 2024, an estimated $479K.
  • CME Group made up 0.68% of Gratus Capital's portfolio in Q2 2024, its #41 holding.
  • Gratus Capital first reported a position in CME Group in Q2 2020 and has held it in 17 quarters since.
  • Gratus Capital's CME Group position peaked at $18.2M in Q1 2024.
  • 1,377 funds tracked by Wall St. Rank held CME Group as of Q2 2024.

Based on Gratus Capital's 13F filing for Q2 2024, filed 25 Jul 2024.